Mansoor Raza Mirza: ESMO is the Meeting Which Brings New Data for Forever Practice-Changing Trials

Gynecologic oncologist Mansoor Raza Mirza from Copenhagen University Hospital is looking forward to ESMO 2024. He eagerly awaits new data on the effectiveness of combining chemoradiation with pembrolizumab for locally advanced cervical cancer, which shows a potential new standard of care, long-term efficacy data from the PRIMA study in ovarian cancer, and insights into the DUO-E trial in endometrial cancer.